Preferred Label : isoquinolines;

MeSH definition : A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed);

Wikipedia link : https://en.wikipedia.org/wiki/Isoquinolines;

Codes EINECS : 204-341-8;

Is substance : O;

Details


Main resources

You can consult :

A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)

https://www.ema.europa.eu/en/medicines/human/EPAR/copiktra
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
duvelisib
duvelisib
drug approval
europe
duvelisib
antineoplastic agents
antineoplastic agents
lymphoma, follicular
leukemia, lymphocytic, chronic, B-Cell
Recurrent Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia
Refractory Follicular Lymphoma
administration, oral
drug monitoring
phosphatidylinositol 3-Kinase
adult
aged
drug interactions
pregnancy
breast feeding
PIK3CG protein, human
Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta Isoform
Copiktra
isoquinolines
purines
isoquinolines
purines
class ib phosphatidylinositol 3-Kinase
Phosphoinositide-3 Kinase Inhibitors
Phosphoinositide-3 Kinase Inhibitors

---
https://www.has-sante.fr/jcms/p_3224928/fr/akynzeo
2020
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
insurance, health, reimbursement
netupitant, palosentron drug combination
palonosetron, combinations
antiemetics
nausea
vomiting
antineoplastic agents
nausea
vomiting
adult
isoquinolines
pyridines
quinuclidines

---
http://www.has-sante.fr/portail/jcms/c_2755488/fr/akynzeo
https://www.has-sante.fr/portail/jcms/c_2755488/fr/akynzeo-palonosetron-netupitant-setron-en-association
2017
false
false
false
France
French
treatment outcome
drug combinations
netupitant
palonosetron, combinations
palonosetron hydrochloride
nausea
nausea
antineoplastic agents
vomiting
vomiting
administration, oral
serotonin 5-HT3 receptor antagonists
Neurokinin-1 receptor antagonists
netupitant, palosentron drug combination
evaluation of the transparency committee
insurance, health, reimbursement
guidelines for drug use
pyridines
isoquinolines
quinuclidines
Palonosetron

---
SUNVEPRA - Summary Basis of Decision (SBD)
Asunaprevir, 100 mg , capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00297
2016
false
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
asunaprevir
asunaprevir
NS3 protein, hepatitis C virus
risk assessment
drug evaluation
drug approval
canada
adult
hepatitis C, chronic
drug therapy, combination
Hepatitis C virus genotype 4 (organism)
Hepatitis C virus genotype 1 (organism)
Cirrhosis of liver due to chronic hepatitis C (disorder)
antiviral agents
antiviral agents
protease inhibitors
protease inhibitors
treatment outcome
asunaprevir
isoquinolines
sulfonamides
isoquinolines
sulfonamides
viral nonstructural proteins

---
http://www.has-sante.fr/portail/jcms/c_2658513/fr/palonosetron-accord
2016
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
palonosetron
Palonosetron 0.25mg/5mL injection solution 5mL vial (product)
palonosetron hydrochloride
isoquinolines
quinuclidines
Palonosetron

---
https://www.ema.europa.eu/medicines/human/EPAR/palonosetron-accord
2016
false
United Kingdom
English
French
syndication feed
chemotherapy-induced nausea and vomiting
treatment outcome
drugs, generic
drug approval
europe
vomiting
nausea
vomiting
nausea
isoquinolines
quinuclidines
palonosetron
serotonin 5-HT3 receptor antagonists
serotonin 5-HT3 receptor antagonists
drug evaluation
package leaflet
summary of product characteristics
isoquinolines
quinuclidines
Palonosetron 0.25mg/5mL injection solution 5mL vial (product)
Palonosetron
Palonosetron

---
https://www.ema.europa.eu/medicines/human/EPAR/palonosetron-hospira
2016
false
United Kingdom
English
French
syndication feed
treatment outcome
chemotherapy-induced nausea and vomiting
drugs, generic
vomiting
nausea
vomiting
nausea
isoquinolines
quinuclidines
palonosetron
serotonin 5-HT3 receptor antagonists
serotonin 5-HT3 receptor antagonists
drug evaluation
package leaflet
summary of product characteristics
isoquinolines
quinuclidines
Palonosetron 0.25mg/5mL injection solution 5mL vial (product)
Palonosetron
Palonosetron

---
http://www.has-sante.fr/portail/jcms/c_2609211/fr/aloxi
http://www.has-sante.fr/portail/jcms/c_2609211/fr/aloxi-palonosetron-antiemetique-injectable
2016
false
France
French
infant
acute disease
chemotherapy-induced nausea and vomiting
guidelines for drug use
isoquinolines
quinuclidines
injections
nausea
vomiting
antiemetics
nausea
vomiting
antineoplastic agents
palonosetron
serotonin 5-HT3 receptor antagonists
evaluation of the transparency committee
Palonosetron 0.25mg/5mL injection solution 5mL vial (product)
Palonosetron

---
https://www.ema.europa.eu/medicines/human/EPAR/Akynzeo
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
netupitant
netupitant
palonosetron, combinations
palonosetron hydrochloride
palonosetron hydrochloride
Drug-Related side effects and adverse reactions
nausea
nausea
antineoplastic agents
vomiting
vomiting
administration, oral
serotonin 5-HT3 receptor antagonists
serotonin 5-HT3 receptor antagonists
Neurokinin-1 receptor antagonists
Neurokinin-1 receptor antagonists
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
netupitant, palosentron drug combination
netupitant, palosentron drug combination
pyridines
pyridines
isoquinolines
quinuclidines
isoquinolines
quinuclidines
Palonosetron
Palonosetron

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=135095&nom=Isoquinoléine
Canada
toxicological data sheet
isoquinoline
isoquinolines

---
https://www.ema.europa.eu/medicines/human/EPAR/Aloxi
2012
false
United Kingdom
English
French
syndication feed
chemotherapy-induced nausea and vomiting
vomiting
nausea
vomiting
nausea
isoquinolines
quinuclidines
palonosetron
serotonin 5-HT3 receptor antagonists
serotonin 5-HT3 receptor antagonists
drug evaluation
package leaflet
summary of product characteristics
isoquinolines
quinuclidines
Palonosetron 0.25mg/5mL injection solution 5mL vial (product)
Palonosetron
Palonosetron

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00004
2012
false
false
false
Canada
Product containing palonosetron (medicinal product)
palonosetron
drug information
isoquinolines
quinuclidines
Palonosetron

---
http://www.has-sante.fr/portail/display.jsp?id=c_487092
2007
false
France
French
isoquinolines
quinuclidines
injections
nausea
vomiting
antiemetics
nausea
vomiting
antineoplastic agents
palonosetron
isoquinolines
quinuclidines
serotonin 5-HT3 receptor antagonists
evaluation of the transparency committee
Palonosetron 0.25mg/5mL injection solution 5mL vial (product)
Palonosetron

---
Nous contacter.
23/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.